Thromboelastographic profiles as a tool for thrombotic risk in digestive tract cancer

Experimental Oncology

Volumn 29, Issue 2, 2007, Pages 111-115

  Papa, M L ^a   Capasso, F ^a   Pudore, L ^a   Torre, S ^a   Mango, S ^a   Russo, V ^a   Delrio, P ^b   Palaia, R ^b   Ruffolo, F ^b   D'Eufemia, M D ^c   De Lucia, D ^c   Napolitano, M ^c   Di Micco, P ^d   Parisi, V ^b  

^a San Giovanni Bosco Hospital   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

^d Fatebenefratelli Hospital of Naples   (Italy)

Author keywords

Cancer; Hypercoagulable state; Surgery; Thromboelastography; Thromboelastometry

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD CLOTTING DISORDER; BLOOD CLOTTING TIME; BLOOD SAMPLING; CANCER PATIENT; COMPLEMENT FIXATION TEST; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; FEMALE; HIGH RISK PATIENT; HUMAN; HYPERCOAGULABILITY; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE PERIOD; RISK FACTOR; THROMBOELASTOGRAPHY; THROMBOSIS; VENOUS THROMBOEMBOLISM;

AGED; AREA UNDER CURVE; BLOOD COAGULATION TESTS; CARCINOMA; CASE-CONTROL STUDIES; FEMALE; HUMANS; KINETICS; MALE; MIDDLE AGED; REFERENCE VALUES; RISK FACTORS; SEX FACTORS; STOMACH NEOPLASMS; THROMBELASTOGRAPHY; THROMBOEMBOLISM;

EID: 34548155256     PISSN: 18129269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Bloom JW, Doggen CGM, Osanto S, Rosendaal FR. Malignancies, prothrombotic mutations and risk of venous thrombosis. JAMA 2005; 293: 715-22.
2. Mannucci PM. The measurement of multifactorial thrombophilia. Thromb Haemost 2002; 88: 1-2.
3. Falanga A, Gordon SG. Isolation and characterization of cancer procoagulant: a cysteine proteinase from malignant tissue. Biochemistry 1985; 24: 5558-67.
4. Trousseau A. Phlegmasia alba dolens. Clinique medicale de l'Hotel-Dieu de Paris. Paris, JB Balliere et Fils, vol 3; 654-712
5. Falanga A, Rickles FR. Pathophisiology of the thrombophilic state in the cancer patients. Sem Thromb Haemost 1999; 25: 173-82.
6. Rickles FR., Patierno S, Fernandez PM. Tissue factor, thrombin, and cancer. Chest 2003; 124: 588-88.
7. Levine MN, Lee AYY. Risk assessment and primary VTE prevention in the cancer patients. Pathophysiol Haemost Thromb 2003, 33: 36-41.
8. Mannucci PM. Markers of hypercoagulability in cancer patients. Haemostasis 1997; 27: 25-31.
9. Parisi V, Capasso F, Pudore L, Torre S, Russo V, Vitale S, Delrio P, Palaia R, Ruffolo F, Papa ML. Nuovi marcatori di trombofilia nelle neoplasie del tratto digestivo. Tumori 2003; 89: 129-32.
10. Papa ML, Capasso F, Pudore L, Torre S, Russo V, Montella M, Delrio P, Palaia R, de Bellis G, Ruffolo F, Parisi V. Hemostatic activation in digestive tract cancer. Haematologica 2004; 89 (S8): 146
11. Lang T, Bauters A, Braun SL, Pötzsch B, von Pape KW, Kolde HJ, Lakner M. Multi-centre investigation on reference ranges for ROTEM thromboelastometry. Blood Coagul Fibrinolysis 2005; 16: 301-10.
12. Hartert H. Blutgerinnungsstudien mit der thrombelastographic, einem neuen untersuchungsverfahren. Klinische Wochenschrift 1948; 26: 577-83.
13. Calatzis A, Fritzsche P, Calatzis A, Kling M, Hipp R, Stemberger A. A comparison of the technical principle of the roTEG coagulation analyser and conventional thrombelastographic systems. Ann Haematol 1996; 72: 90.
14. Sorensen B, Johansen P, Christiansen K, Woelke M, Ingerslev J. Whole blood coagulation thrombelastographic profiles employing minimal tissue factor activation. J Thromb Haemost 2003; 1: 551-8.
15. Proctor RR, Rapaport SI. The partial thromboplastin time with kaolin. A simple screening test for first stage plasma clotting factor deficiencies. Am J Clin Path 1961; 36: 212-9.
16. Yamada K, Meguro T. A new APTT assay employing a chromogenic substrate and a centrifugal autoanalyzer. Thromb Res 1979; 15: 351-8.
17. Hemker HC, Wielders S, Kessels H, Beguin S. Continuous registration of thrombin generation in plasma, its use for the determination of the thrombin potential. Thromb Haemost 1993; 70: 617-24.
18. Tripodi A, Mannucci PM. Laboratory investigation of thrombophilia. Clin Chem 2001; 47: 597-606
19. Sorensen B, Ingerslev J. Whole blood clot formation phenotypes in hemophilia A and rare coagulation disorders. Patterns of response to recombinant factor VIIa. J Thromb Haemost 2003; 2: 102-10.
20. Schobersberger W, Fries D, Mittermayr M, Innerhofer P, Sumann G, Schobersberger B, Klinger A, Stollnberger V, Fischbach U, Gunga HC. Changes of biochemical markers and functional tests for clot formation during long-haul flights. Thromb Res 2003; 108: 19-24.
21. Schobersberger W, Mittermayr M, Innerhofer P, Sumann G, Schobersberger B, Klingler A, Simmer M, Streif W, Fischbach U, Fries D. Coagulation changes and edema formation during long-distance bus travel. Blood Coagul Fibrinolysis 2004; 15: 419-25.
22. Spiel AO, Mayr FB, Firbas C, Quehenberger P, Jilma B. Validation of rotation thrombelastography in a model of systemic activation of fibrinolysis and coagulation in humans. J Thromb Haemost 2006; 4: 411-6.
23. McCrath DJ, Cerboni E, Frumento RJ, Hirsh AJ, Bennett-Guerrero E. Thrombelastography maximum amplitude predicts postoperative thrombotic complications including myocardial infarction. Anesth Analg 2005; 100: 1576-83.
24. Donati MB, Poggi A. Malignancy and haemostasis. Br J Haematol 1980; 44: 173-82.
25. Geerts WH, Pineo GF, Heit JA, Bergqvist D, Lassen MR, Colwell CW, Ray JG. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126: 338S-400.
26. Anderson L, Quasim I, Soutar R, Steven M, Macfie A, Korte W. An audit of red cell and blood product use after the institution of thromboelastometry in a cardiac intensive care unit. Transfusion Medicine 2006; 16: 31-9.